Lactobacillus acidophilus LA-5
Lactobacillus acidophilus LA-5 is a commercially used probiotic strain studied primarily for its survivability in fermented food matrices such as yogurt, cheese, and whey-based beverages. The indexed literature is largely in vitro, focusing on growth characteristics, gastrointestinal transit tolerance, and synbiotic formulations with other probiotic species. One 2024 in vitro study explored apoptosis-related activity in a cancer cell model, though this work is early-stage and does not constitute clinical evidence of efficacy. Strain-specific human trial data is not present in the indexed literature.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 224 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 89 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
+14 more symptoms
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
565 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 42287602 →Multi-Analytical Approach for the Quality and Functional Evaluation of Probiotic Formulations: The Case of Lactobacillus acidophilus LA-5®Commercial Products· Probiotics and Antimicrobial Proteins · 2026
-
[2]
PMID 42697830 →Effects of paraprobiotic Lactobacillus acidophilus LA ‐5 on PANoptosis , oxidative stress and inflammation in acetic acid‐induced ulcerative colitis· Journal of the Science of Food and Agriculture · 2026
-
[3]
PMID 41491715 →Probiotics in the ICU: a scoping review of evidence for infection prevention· Journal of Translational Medicine · 2026
-
[4]
Source →Exploring the immune modulatory effects of probiotics in autoimmune diseases· International Journal of Immunology Research · 2026
-
[5]
PMID 41255078 →Probiotic Blend of Lactobacillus acidophilus LA‐5 and Bifidobacterium animalis ssp. Lactis BB‐12 in Non‐constipated Irritable Bowel Syndrome: A Double‐Blind Randomized Placebo‐Controlled Trial· Journal of Gastroenterology and Hepatology · 2025
-
[6]
PMID 38658619 →A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for depression in irritable bowel syndrome· Scientific Reports · 2024
-
[7]
PMID 39102225 →Bifidobacterium and Lactobacillus Probiotics and Gut Dysbiosis in Preterm Infants· JAMA Pediatrics · 2024
-
[8]
PMID 38674780 →Lactobacillus acidophilus LA-5 Ameliorates Inflammation and Alveolar Bone Loss Promoted by A. actinomycetemcomitans and S. gordonii in Mice and Impacts Oral and Gut Microbiomes· Microorganisms · 2024
-
[9]
PMID 36422363 →Probiotic Therapy with Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis Results in Infarct Size Limitation in Rats with Obesity and Chemically Induced Colitis· Microorganisms · 2022
-
[10]
PMID 35807801 →A Four-Probiotic Regime to Reduce Surgical Site Infections in Multi-Trauma Patients· Nutrients · 2022